EPS Creative Health Technology Group Ltd.

  • Market Cap: N/A
  • Industry: Footwear
  • ISIN: KYG3121P1054
HKD
0.55
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
544.52
644.62
452.91
519.95
405.44
537.41
433.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
544.52
644.62
452.91
519.95
405.44
537.41
433.00
Raw Material Cost
449.94
545.36
385.06
443.17
351.41
445.21
349.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
42.96
50.94
51.32
34.01
18.14
19.78
23.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.31
7.07
5.79
4.61
0.14
0.15
0.11
Selling and Distribution Expenses
84.92
103.81
96.91
79.96
48.27
60.31
51.78
Other Expenses
-3.32
-3.37
-4.41
-2.74
-1.83
-1.99
-2.39
Total Expenditure (Excl Depreciation)
552.97
673.48
495.01
534.38
399.69
505.52
401.31
Operating Profit (PBDIT) excl Other Income
-8.4
-28.900000000000002
-42.1
-14.399999999999999
5.8
31.9
31.7
Other Income
45.87
-4.18
-0.26
-3.14
-1.22
1.20
1.14
Operating Profit (PBDIT)
53.23
-19.02
-37.88
-13.97
7.58
35.30
33.92
Interest
8.31
7.07
5.79
4.61
0.14
0.15
0.11
Exceptional Items
4.30
16.06
0.00
-0.56
2.73
-5.15
0.00
Gross Profit (PBDT)
94.58
99.26
67.85
76.78
54.03
92.20
83.47
Depreciation
15.81
14.02
4.48
3.60
3.04
2.21
1.08
Profit Before Tax
33.42
-24.05
-48.16
-22.74
7.14
27.80
32.72
Tax
3.02
2.44
2.12
3.53
0.63
5.07
5.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
38.59
-22.07
-45.74
-22.60
6.50
22.73
27.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
38.59
-22.07
-45.74
-22.60
6.50
22.73
27.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.19
-4.43
-4.55
-3.67
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.39
-26.50
-50.29
-26.27
6.50
22.73
27.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
120.68
65.36
87.64
131.32
133.15
126.53
111.91
Earnings per share (EPS)
0.07
-0.04
-0.09
-0.05
0.01
0.05
0.05
Diluted Earnings per share
0.07
-0.04
-0.09
-0.05
0.01
0.05
0.05
Operating Profit Margin (Excl OI)
-1.55%
-4.48%
-9.3%
-2.77%
1.42%
5.93%
7.32%
Gross Profit Margin
9.04%
-1.56%
-9.64%
-3.68%
2.51%
5.58%
7.81%
PAT Margin
7.09%
-3.42%
-10.1%
-4.35%
1.6%
4.23%
6.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -15.53% vs 42.33% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 214.72% vs 47.32% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 150.00% vs 60.64% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.90% vs 22.41% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of EPS Creative Health Technology Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
544.52
1,122.18
-577.66
-51.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
544.52
1,122.18
-577.66
-51.48%
Raw Material Cost
449.94
658.42
-208.48
-31.66%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
42.96
82.36
-39.40
-47.84%
Power Cost
0
0
0.00
Manufacturing Expenses
8.31
14.17
-5.86
-41.35%
Selling and Distribution Expenses
84.92
357.31
-272.39
-76.23%
Other Expenses
-3.32
-8.28
4.96
59.90%
Total Expenditure (Excl Depreciation)
552.97
1,029.44
-476.47
-46.28%
Operating Profit (PBDIT) excl Other Income
-8.45
92.74
-101.19
-109.11%
Other Income
45.87
51.16
-5.29
-10.34%
Operating Profit (PBDIT)
53.23
158.47
-105.24
-66.41%
Interest
8.31
14.17
-5.86
-41.35%
Exceptional Items
4.30
0.00
4.30
Gross Profit (PBDT)
94.58
463.76
-369.18
-79.61%
Depreciation
15.81
61.34
-45.53
-74.23%
Profit Before Tax
33.42
82.96
-49.54
-59.72%
Tax
3.02
40.95
-37.93
-92.63%
Provisions and contingencies
0
0
0.00
Profit After Tax
38.59
29.72
8.87
29.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
38.59
29.72
8.87
29.85%
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.19
1.60
-9.79
-611.88%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.39
31.33
-0.94
-3.00%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
120.68
1,421.43
-1,300.75
-91.51%
Earnings per share (EPS)
0.07
0.04
0.03
75.00%
Diluted Earnings per share
0.07
0.04
0.03
75.00%
Operating Profit Margin (Excl OI)
-1.55%
4.10%
0.00
-5.65%
Gross Profit Margin
9.04%
12.86%
0.00
-3.82%
PAT Margin
7.09%
2.65%
0.00
4.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 54.45 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -15.53% vs 42.33% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3.04 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 214.72% vs 47.32% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.74 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 150.00% vs 60.64% in Mar 2024

Annual - Interest
Interest 0.83 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.90% vs 22.41% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.55%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024